CoChat

Editorial: Thyroid Function and Aging: Do Serum 3,5,3′-Triiodothyronine and Thyroid-Stimulating Hormone Concentrations Give the Janus Response?

Open access
Mariotti, Stefano · 2005 · The Journal of Clinical Endocrinology & Metabolism
Cited by 38

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Janus: Roman god of doorways and archways, after whom the month of January is named. Often depicted as a double-faced head, he was a deity of beginnings and ends. Britannica Concise Encyclopedia Several thyroid function abnormalities are observed in the elderly (1, 2). An increased prevalence of serum thyroid antibodies and clinical and subclinical hypothyroidism have been consistently reported, reaching a value as high as 20% in women older than 60–65 yr (3). The prevalence of subclinical hyperthyroidism is also increased in aged subjects of both sexes, affecting 1–1.5% of the general population in iodine-sufficient areas (3) and up to 7–8% in iodine-deficient areas (4). Moreover, the coexistence of several age-associated diseases may account for serum thyroid hormone and TSH abnormalities characteristic of the nonthyroidal illness (NTI) syndrome (1). Finally, an age-dependent decline of thyroid function, at least partially independent from associated NTI, has been documented, particularly in the oldest-old (>85 yr) population (1, 5). Despite a very large number of studies, no consensus has been reached so far about the actual health impact of subclinical thyroid dysfunction, and different recommendations have been made recently about screening and treating these conditions (3, 6–10). One of the strongest arguments employed in favor of active detection and treatment of subclinical thyroid dysfunction is the possibility that subclinical thyroid disease may directly or indirectly influence the aging process and/or the pathogenesis of age-associated diseases. Several investigators found a significant association between thyroid autoimmunity and/or subclinical hypothyroidism and atherosclerotic cardiovascular disease, possibly mediated by dislipidemia and poorly defined autoimmune mechanisms, but this finding has not been confirmed by others (see Ref.1 for review). Divergent results were also obtained in recent large epidemiolgical studies, two supporting a role of subclinical hypothyroidism in atherosclerosis and myocardial infarction in middle-aged Dutch women (11) and in Dutch males aged less than 50 yr (21), and two failing to find any relationship between thyroid autoimmunity, mild thyroid failure, and ischemic heart disease in an English community (12) and in a cohort of subjects older than 65 yr from New Mexico (22). Recently, a significant increase of all-cause mortality was observed in a cohort of middle-aged Japanese men with subclinical hypothyroidism followed for 12 yr (13). However, no agreement has been reached in favor or against active screening and/or treatment of mild thyroid failure (3, 6–10); l-T4 therapy has been discouraged in aged subjects, because the increased oxygen consumption consequent to thyroid hormone administration could be dangerous in the presence of coexisting coronary heart disease. Subclinical hyperthyroidism may also represent an important health problem in the elderly. A large longitudinal study of subjects aged 60 yr or older, forming part of the Framingham population, provided evidence for three times increased risk of atrial fibrillation in people with suppressed (≤0.1 mU/liter) serum TSH concentrations (14). The concept that mild thyroid hormone excess might result in an increase in cardiovascular morbidity is also supported by a subsequent large longitudinal study carried out in the UK in subjects aged 60 yr and older (15) followed for 10 yr. A significant increase in all-cause mortality (mostly accounted by mortality for cardiovascular diseases) was found from the second to the fifth year of follow-up in subjects with low, but not necessarily undetectable, serum TSH concentration (≤0.5 mU/liter) at the beginning of the study. Several questions remain unsolved, particularly the potential interference of associated NTI and the lack of thyroid function data during the follow-up. Subclinical hyperthyroidism might also be implicated in other health problems of the elderly. For example, both exogenous and endogenous subclinical hyperthyroidism are associated with reduced bone mineral content, which could lead to an increased risk of fractures (16). Moreover, in a short-term (2 yr) longitudinal study on 1843 Dutch subjects aged 55 yr or older, low serum TSH and higher serum T4 concentration were associated with a more than 3-fold increased risk of dementia and Alzheimer disease (17). In contrast to subclinical hypothyroidism, the recommendations of recent guidelines tend to support active treatment of most patients with subclinical hyperthyroidism, despite an almost complete lack of evidence-based data on the effectiveness of antithyroid therapy (3, 7, 9). This attitude is probably the consequence of a prudent clinical approach, given the universally recognized dangerous effects of excess thyroid hormone on the heart and skeleton. Until recently, no studies were available on the health consequences of subtle thyroid dysfunction on the oldest-old fraction of the elderly po

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2005-2214

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 38

Metadata

Authors
Mariotti, S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-12
Volume
90
Issue
12
Pages
6735-6737
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2129798699
Cited by
38
References
10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Editorial: Thyroid Function and Aging: Do Serum 3,5,3′-Triiodothyronine and Thyroid-Stimulating Hormone Concentrations Give the Janus Response? https://app.cochat.ai/papers/10.1210/jc.2005-2214
The paper
Mariotti, S. (2005). Editorial: Thyroid Function and Aging: Do Serum 3,5,3′-Triiodothyronine and Thyroid-Stimulating Hormone Concentrations Give the Janus Response? The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2005-2214

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.